Frontiers in Immunology | Cancer Immunity and Immunotherapy

Case Report

Published on 10 Jul 2023

Hilar/mediastinal and cutaneous drug-induced sarcoidosis-like reaction associated with immune checkpoint inhibitors in metastatic colorectal cancer: a case report

in Cancer Immunity and Immunotherapy

Tamotsu Sagawa
Yasushi Sato
Hiroyuki Nagashima
Kohichi Takada
Mamoru Takahashi
Masahiro Hirakawa
Kyoko Hamaguchi
Fumito Tamura
Koshi Fujikawa
Koichi Okamoto

Frontiers in Immunology

doi 10.3389/fimmu.2023.1203621

3,674 views
6 citations

Original Research

Published on 10 Jul 2023

Construction of the systemic anticancer immune environment in tumour-bearing humanized mouse by using liposome-encapsulated anti-programmed death ligand 1 antibody-conjugated progesterone

in Cancer Immunity and Immunotherapy

Yoshie Kametani
Ryoji Ito
Shino Ohshima
Yoshiyuki Manabe
Yusuke Ohno
Tomoka Shimizu
Soga Yamada
Nagi Katano
Daiki Kirigaya
Keita Ito

Frontiers in Immunology

doi 10.3389/fimmu.2023.1173728

4,676 views
5 citations

Original Research

Published on 10 Jul 2023

A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Yichao Han
Si-Yang Maggie Liu
Runsen Jin
Wangyang Meng
Yi-Long Wu
Hecheng Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1178193

7,447 views
6 citations

Review

Published on 10 Jul 2023

Immune escape and resistance to immunotherapy in mismatch repair deficient tumors

in Cancer Immunity and Immunotherapy

Guillaume Mestrallet
Matthew Brown
Cansu Cimen Bozkus
Nina Bhardwaj

Frontiers in Immunology

doi 10.3389/fimmu.2023.1210164

13,150 views
50 citations

Original Research

Published on 07 Jul 2023

CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target

in Cancer Immunity and Immunotherapy

Qianwei Jiang
Jing Kuai
Zhongyi Jiang
Weitao Que
Pusen Wang
Wenxin Huang
Wei Ding
Lin Zhong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1158360

5,503 views
8 citations

Original Research

Published on 07 Jul 2023

Integrated analyses of single-cell transcriptomics identify metastasis-associated myeloid subpopulations in breast cancer lung metastasis

in Cancer Immunity and Immunotherapy

Zhen Huang
Dawei Bu
Nan Yang
Wenwen Huang
Liyin Zhang
Xiaoxue Li
Bi-Sen Ding

Frontiers in Immunology

doi 10.3389/fimmu.2023.1180402

7,713 views
6 citations

Case Report

Published on 07 Jul 2023

Case Report: Chemoimmunotherapy in microsatellite-instability-high advanced goblet cell carcinoma of the colon

in Cancer Immunity and Immunotherapy

Arda Ulaş Mutlu
Erman Aytaç
Mehmet Gülmez
Sibel Erdamar
Leyla Özer

Frontiers in Immunology

doi 10.3389/fimmu.2023.1160586

3,842 views

Original Research

Published on 07 Jul 2023

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Weibiao Zeng
Jin Wang
Jian Yang
Zhike Chen
Yuan Cui
Qifan Li
Gaomeng Luo
Hao Ding
Sheng Ju
Baisong Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1217590

5,852 views
15 citations

Original Research

Published on 07 Jul 2023

A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors

in Cancer Immunity and Immunotherapy

Silvia Mezi
Giulia Pomati
Giulia Fiscon
Sasan Amirhassankhani
Ilaria Grazia Zizzari
Chiara Napoletano
Aurelia Rughetti
Ernesto Rossi
Giovanni Schinzari
Giampaolo Tortora

Frontiers in Immunology

doi 10.3389/fimmu.2023.1199089

2,645 views
1 citation

Original Research

Published on 07 Jul 2023

Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China

in Cancer Immunity and Immunotherapy

Yuting Yan
Rui Lv
Tingyu Wang
Ying Yu
Yanshan Huang
Wenjie Xiong
Yuxi Li
Weiwei Sui
Qi Wang
Wenyang Huang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1184395

3,966 views
4 citations

Review

Published on 07 Jul 2023

Targeting LSD1 in tumor immunotherapy: rationale, challenges and potential

in Cancer Immunity and Immunotherapy

Lei Bao
Ping Zhu
Yuan Mou
Yinhong Song
Ye Qin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1214675

7,336 views
5 citations

Review

Published on 07 Jul 2023

HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy

in Cancer Immunity and Immunotherapy

Xin Wan
Ken H. Young
Ou Bai

Frontiers in Immunology

doi 10.3389/fimmu.2023.1216610

5,856 views
5 citations

Original Research

Published on 07 Jul 2023

Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study

in Cancer Immunity and Immunotherapy

Jian Huang
Zhen-Guang Wang
Qi-Fei Tao
Yun Yang
Sheng-Xian Yuan
Fang-Ming Gu
Hui Liu
Ze-Ya Pan
Bei-Ge Jiang
Wan Yee Lau

Frontiers in Immunology

doi 10.3389/fimmu.2023.1198562

3,044 views
2 citations

Editorial

Published on 06 Jul 2023

Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors

in Cancer Immunity and Immunotherapy

Silvia Pesce
Ombretta Melaiu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1246695

964 views

Original Research

Published on 06 Jul 2023

β-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in BrafV600E-driven thyroid cancer cells

in Cancer Immunity and Immunotherapy

Minjing Zou
Suhad Al-Yahya
Monther Al-Alwan
Huda A. BinEssa
Khalid S. A. Khabar
Falah Almohanna
Abdullah M. Assiri
Abdulmohsen Altaweel
Amal Qattan
Brian F. Meyer

Frontiers in Immunology

doi 10.3389/fimmu.2023.1171816

3,260 views
1 citation

Mini Review

Published on 06 Jul 2023

The potential of activator protein 1 (AP-1) in cancer targeted therapy

in Cancer Immunity and Immunotherapy

Dandan Song
Yan Lian
Lin Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1224892

15,489 views
56 citations